Frontiers in Immunology (Aug 2020)

Bta-miR-98 Suppresses Replication of Caprine Parainfluenza Virus Type 3 Through Inhibiting Apoptosis by Targeting Caspase-3

  • Jizong Li,
  • Jizong Li,
  • Jizong Li,
  • Chunyan Zhong,
  • Chunyan Zhong,
  • Zheng Liao,
  • Zheng Liao,
  • Li Mao,
  • Li Mao,
  • Wenliang Li,
  • Wenliang Li,
  • Min Sun,
  • Maojun Liu,
  • Maojun Liu,
  • Xinqin Ji,
  • Chuanmin Liu,
  • Tao Xue,
  • Leilei Yang,
  • Wenwen Zhang

DOI
https://doi.org/10.3389/fimmu.2020.01575
Journal volume & issue
Vol. 11

Abstract

Read online

Caprine parainfluenza virus type 3 (CPIV3) is an emerging respiratory pathogen that affects the sheep and goat industry in China and possibly other countries around the world. Accumulating evidence suggests that microRNAs play important roles in regulating virus-host interactions and can suppress or facilitate viral replication. In this study, we showed that CPIV3 infection induced apoptosis in Madin-Darby bovine kidney (MDBK) cells, as determined by morphological changes and flow cytometry. Caspase activity and the expression of pro-apoptotic genes further indicated that CPIV3 induced apoptosis by activating both the intrinsic and extrinsic pathways. We also demonstrated the involvement of bta-microRNA-98 (bta-miR-98) in regulating CPIV3-induced apoptosis. Bta-miR-98 was downregulated in MDBK cells infected with CPIV3. Overexpression of bta-miR-98 significantly decreased the activities of caspase-3, −8, and −9. Conversely, inhibition of bta-miR-98 had completely opposite effects. Furthermore, our data showed that bta-miR-98 markedly affected CPIV3 replication by regulating apoptosis. Importantly, we found that bta-miR-98 modulated CPIV3-induced apoptosis by targeting caspase-3, an effector of apoptosis. Collectively, our results may suggest that CPIV3 infection induced apoptosis and downregulated the levels of bta-miR-98, and this miRNA regulated viral replication through effected apoptosis. This study contributes to our understanding of the molecular mechanisms underlying CPIV3 pathogenesis.

Keywords